
Biopharmaceutical development has revolutionized medicine by introducing therapies derived from biological systems, offering more precise and effective treatments for various diseases. As noted by Shane Schaffer, unlike traditional chemical-based drugs, biologics such as monoclonal antibodies, gene therapies, and RNA-based medicines are designed to target specific molecular mechanisms. This field involves multiple stages, from initial discovery to large-scale production, requiring collaboration across scientific disciplines. Despite technological advancements, challenges such as high costs, regulatory hurdles, and complex manufacturing processes remain. However, innovations in artificial intelligence, automation, and personalized medicine are shaping the future, making therapies more accessible and … Read More..